| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/02/1998 | CN1191862A 8-substituted-1,3,8-triaza-spiro £4,5| decan-4-on derivatives |
| 09/02/1998 | CN1191753A Dual action 2', 5'-oligoadenylate antiviral derivatives and uses thereof |
| 09/02/1998 | CN1191737A Liniment Tongbining for cold-type arthralgia |
| 09/02/1998 | CN1191723A Compound eye drops for preventing and treating eye infection and its preparation |
| 09/02/1998 | CN1191722A Improved Amoxyicillin and Cleve's acid compound preparation |
| 09/02/1998 | CN1039644C Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds and its application |
| 09/02/1998 | CN1039642C Derivative of hexahydronaphthalene ester, their preparation and their therapeutic uses |
| 09/02/1998 | CN1039623C Medicinal composition for preventing & curing kinetosis syndrome and its preparation method |
| 09/02/1998 | CN1039622C New use for large ring lactone compound |
| 09/01/1998 | US5801256 Method for the synthesis of 8-C-β-D 2'-O-(E)-cinnamoyl!glycopyranosyl-2- 2-hydroxy!propyl-7-methoxy-5-methylchromone |
| 09/01/1998 | US5801253 Retinoic acid X-receptor ligands |
| 09/01/1998 | US5801246 Bactericides |
| 09/01/1998 | US5801242 Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 09/01/1998 | US5801235 Oligonucleotides with anti-cytomegalovirus activity |
| 09/01/1998 | US5801234 Polynucleotide encoding saliva binding protein |
| 09/01/1998 | US5801229 Radiation sensitizers; antitumor agents |
| 09/01/1998 | US5801203 Nitroglycerine patch |
| 09/01/1998 | US5801202 Amine derivatives for treatment of skin disorders |
| 09/01/1998 | US5801201 1-phenyl-2-dimenthylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients |
| 09/01/1998 | US5801200 Methods and materials for the diagnosis and treatment of conditions such as stroke |
| 09/01/1998 | US5801199 Pharmaceutical composition for treating acute rhinitis |
| 09/01/1998 | US5801198 Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues |
| 09/01/1998 | US5801197 Rotamase enzyme activity inhibitors |
| 09/01/1998 | US5801196 Methods of using emu oil and active fractions thereof as an insect repellent |
| 09/01/1998 | US5801195 Immunotherapeutic aryl amides |
| 09/01/1998 | US5801191 Taxoids |
| 09/01/1998 | US5801190 Fused pyrrolo 2,3-C! carbazole-6-ones |
| 09/01/1998 | US5801188 Clonidine therapy enhancement |
| 09/01/1998 | US5801187 Heterocyclic esters and amides |
| 09/01/1998 | US5801185 Method of treating Tay-Sachs disease |
| 09/01/1998 | US5801184 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
| 09/01/1998 | US5801183 Heterocyclc alcohols for nervous system disorders |
| 09/01/1998 | US5801181 Amino alcohol substituted cyclic compounds |
| 09/01/1998 | US5801180 Antiischemic agents and cardiovascular disorders |
| 09/01/1998 | US5801179 Treatment of migraines, hypotension, venous insufficiency |
| 09/01/1998 | US5801177 Method for controlling and/or lowering serum glucose and fatty acid concentrations and hypertensive blood pressure in non-insulin-dependent diabetic patients |
| 09/01/1998 | US5801176 Substituted benzothienylpiperazines and their use |
| 09/01/1998 | US5801174 Cerebrovascular disorders |
| 09/01/1998 | US5801171 Use of 3, 5-diamino-6-(2,3-dichlorophenyl)-1, 2, 4-triazine isethionate for the treatment and prevention of dependence; tolerance and sensitization of drugs |
| 09/01/1998 | US5801170 Heterocyclic biphenylylamides useful as 5HT1D antagonists |
| 09/01/1998 | US5801167 Camptothecin derivatives and process for their preparation |
| 09/01/1998 | US5801165 Antiinflammatory, immunosuppressive and antialleric 16, 17-alkylidioxy-steroids |
| 09/01/1998 | US5801164 Methods of treating osteoporosis prophylactically or therapeutically |
| 09/01/1998 | US5801163 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 09/01/1998 | US5801162 Containing tissue plasminogen activator |
| 09/01/1998 | US5801161 Vitamin b12 deficiency |
| 09/01/1998 | US5801160 Method of protecting brain tissue from cerebral infarction subsequent to ischemia |
| 09/01/1998 | US5801159 Method and composition for inhibiting cellular irreversible changes due to stress |
| 09/01/1998 | US5801157 Plasmid contained in oil in water or water in oil emulsion and comprising protein, glycoprotein or peptide |
| 09/01/1998 | US5801156 Macular degeneration |
| 09/01/1998 | US5801153 Method of enhancing the antimicrobial properties of antibacterial antibiotics to massively control and prevent bacterial, fungal, and viral diseases in plants |
| 09/01/1998 | US5801152 Antracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 09/01/1998 | US5801144 Use of a compound for the manufacture of a medicament for the treatment of HIV infection |
| 09/01/1998 | US5801023 Insecticides, antihelminitics; applcation in animal and human health, agriculture, and horticulture; cultivation of aspergillus |
| 09/01/1998 | US5801014 Growth differentiation factor-5 |
| 09/01/1998 | US5801012 Methods and compositions for generating angiostatin |
| 09/01/1998 | US5800980 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization |
| 09/01/1998 | US5800835 Preparation for improving the blood supply containing hard magnetic particles |
| 09/01/1998 | US5800830 Gluconic acid salt, sodium chloride and active material for health |
| 09/01/1998 | US5800826 Sunscreen compositions containing damaged RNA fragments |
| 09/01/1998 | US5800812 Methods of use of mononuclear phagocytes to promote axonal regeneration |
| 09/01/1998 | US5800809 Drug composition containing polyacryloyloxyethyl-n,n-dimethylbenzyl ammonium salt for lowering blood cholesterol levels |
| 09/01/1998 | US5800808 Copolymer-1 improvements in compositions of copolymers |
| 09/01/1998 | US5800807 Ophthalmic compositions including glycerin and propylene glycol |
| 09/01/1998 | US5800685 Electrically conductive adhesive hydrogels |
| 09/01/1998 | US5800596 Water-in-oil emulsion containing retinol, its use and its packaging |
| 09/01/1998 | US5800385 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 09/01/1998 | CA2166903C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 09/01/1998 | CA2086874E Methods for administration of taxol |
| 09/01/1998 | CA1340023C Tetrapyrrole aminocarboxylic acids |
| 09/01/1998 | CA1340021C Anthracycline derivatives having cytostatic activity |
| 08/28/1998 | CA2229707A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 08/27/1998 | WO1998037240A1 Anti-sense oligonucleotide pharmacological agents |
| 08/27/1998 | WO1998037222A1 Method for reversible immobilizing oligo- and/or polysaccharides |
| 08/27/1998 | WO1998037218A1 Hydroxyazepanes as inhibitors of glycosidase and hiv protease |
| 08/27/1998 | WO1998037192A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 08/27/1998 | WO1998037188A1 OLIGONUCLEOTIDES SPECIFIC FOR THE marORAB OPERON |
| 08/27/1998 | WO1998037111A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein |
| 08/27/1998 | WO1998037098A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
| 08/27/1998 | WO1998037091A2 Modified retinoblastoma tumor suppressor proteins |
| 08/27/1998 | WO1998037089A2 Matrix derived anti-hiv peptides and transdominant proteins |
| 08/27/1998 | WO1998037085A1 Netrin receptors |
| 08/27/1998 | WO1998037082A1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION |
| 08/27/1998 | WO1998037080A1 Compounds for inhibition of gastric acid secretion |
| 08/27/1998 | WO1998037079A1 N-heterocyclic derivatives as nos inhibitors |
| 08/27/1998 | WO1998037077A1 Calcitonin mimetics |
| 08/27/1998 | WO1998037075A1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/27/1998 | WO1998037072A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 08/27/1998 | WO1998037071A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| 08/27/1998 | WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 08/27/1998 | WO1998037057A1 Preparation of acid amides and metallisation of compounds |
| 08/27/1998 | WO1998036784A1 Coated implantable medical device |
| 08/27/1998 | WO1998036779A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 08/27/1998 | WO1998036776A2 Gel delivery vehicles for anticellular proliferative agents |
| 08/27/1998 | WO1998036773A1 Therapeutic uses for antioxidants |
| 08/27/1998 | WO1998036770A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor |
| 08/27/1998 | WO1998036755A1 Sulfonylurea-glitazone synergistic combinations for diabetes |
| 08/27/1998 | WO1998036754A1 Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol |
| 08/27/1998 | WO1998036753A1 Tazarotene and corticosteroid treatment for psoriasis |
| 08/27/1998 | WO1998036752A1 Methods for preventing and treating pestivirus infection and associated diseases |